Association between reproductive factors with lung cancer incidence and mortality: A pooled analysis of over 308,000 females in the Asia cohort consortium
Xin Yin,Rie Kishida,Sarah Krull Abe,Rashedul Islam,Shafiur Rahman,Eiko Saito,Qing Lan,Batel Blechter,Melissa Merritt,Ji‐Yeob Choi,Aesun Shin,Ryoko Katagiri,Xiao‐Ou Shu,Norie Sawada,Akiko Tamakoshi,Woon‐Puay Koh,Ichiro Tsuji,Chisato Nagata,Sue K. Park,Sun‐Seog Kweon,Yu‐Tang Gao,Shoichiro Tsugane,Takashi Kimura,Jian‐Min Yuan,Yukai Lu,Seiki Kanemura,Yumi Sugawara,Keiko Wada,Min‐Ho Shin,Habibul Ahsan,Paolo Boffetta,Kee Seng Chia,Keitaro Matsuo,You‐Lin Qiao,Nathaniel Rothman,Wei Zheng,Manami Inoue,Daehee Kang,Wei Jie Seow,Md. Rashedul Islam,Md. Shafiur Rahman
DOI: https://doi.org/10.1002/ijc.34866
2024-02-22
International Journal of Cancer
Abstract:What's new? Hormonal etiology may play a direct role in the development of lung cancer among women, and associations between reproductive factors and lung cancer risk have been assessed. However, the findings are conflicting, particularly between Asian and Western studies. In this large prospective study, a pooled analysis of 308,949 female participants from 11 cohorts in four Asian countries indicates that Asian parous women, especially those who have one or two children, have a lower risk of lung cancer incidence and mortality than nulliparous women. Ever‐use of hormone replacements increased the risk of non‐small cell lung cancer and lung adenocarcinoma. Previous studies have investigated the association between reproductive factors and lung cancer risk; however, findings have been inconsistent. In order to assess this association among Asian women, a total of 308,949 female participants from 11 prospective cohorts and four Asian countries (Japan, Korea, China, and Singapore) were included. Cox proportional hazards regression models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CIs). A total of 3,119 primary lung cancer cases and 2247 lung cancer deaths were identified with a mean follow‐up of 16.4 years. Parous women had a lower risk of lung cancer incidence and mortality as compared with nulliparous women, with HRs of 0.82 (95% CI = 0.70–0.96) and 0.78 (95% CI = 0.65–0.94). The protective association of parity and lung cancer incidence was greater among ever‐smokers (HR = 0.66, 95% CI = 0.49–0.87) than in never‐smokers (HR = 0.90, 95% CI = 0.74–1.09) (P‐interaction = 0.029). Compared with age at first delivery ≤20 years, older age at first delivery (21–25, ≥26 years) was associated with a lower risk of lung cancer incidence and mortality. Women who ever used hormone replacements had a higher likelihood of developing non‐small cell lung cancer (HR = 1.31, 95% CI = 1.02–1.68), compared to those who never used hormone replacements. Future studies are needed to assess the underlying mechanisms, the relationships within these female reproductive factors, and the potential changes in smoking habits over time.
oncology